Pure Global

PYROFEN 120 MG/5 ML PEDIATRIC ORAL SUSPENSION, 150 ML - Turkey License 875f116a820f15b95daa2428a9c11d76

Access comprehensive regulatory information for PYROFEN 120 MG/5 ML PEDIATRIC ORAL SUSPENSION, 150 ML in Turkey's pharmaceutical market through Pure Global AI's free database. This pharmaceutical product is licensed under Turkey number 875f116a820f15b95daa2428a9c11d76 with license number 2022/785and contains active ingredient Parasetamol . The license is held by DEVA HOLDฤฐNG A.ลž..

This page provides complete pharmaceutical specifications, regulatory compliance details. Pure Global AI offers free access to 21,000+ Turkish pharmaceutical product licenses, helping global pharma companies navigate Turkey SFDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
21,000+ Products
875f116a820f15b95daa2428a9c11d76
License Details
Turkey SFDA License: 875f116a820f15b95daa2428a9c11d76
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Product Details

PYROFEN 120 MG/5 ML PEDIATRIC ORAL SUSPENSION, 150 ML
TR: PฤฐROFEN 120 MG/5 ML PEDฤฐATRฤฐK ORAL SรœSPANSฤฐYON, 150 ML
Pharmaceutical Product

License Details

875f116a820f15b95daa2428a9c11d76

2022/785

8699525707703

N02BE01

License Holder Information

Active Ingredient

Parasetamol

License Information

Dec 22, 2022